Incorporated in 2005, Laurus Labs Ltd is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.
Laurus Labs operates in four business lines:
1. Generics active pharmaceutical ingredients (APIs) - The development, manufacture and sale of APIs and advanced intermediates.
2. Generics finished dosage forms (FDFs) - The development and manufacture of oral solid formulations.
3. Synthesis - Contract development and manufacturing services for global pharmaceutical companies.
4. Ingredients - The manufacture and sale of specialty ingredients for use in the nutraceutical and cosmeceutical sectors.
Key Highlights:
1. Laurus Labs launched 59 products since our inception in 2005.
2. Nine out of the 10 largest generic pharmaceutical companies in the world are its customers.
3. Laurus Labs employed 587 scientists at our R&D center in Hyderabad and 12 scientists at R&D centre in Greater Boston USA.
4. The Company owned 32 patents and had 150 pending patent applications, in several countries.
5. Company has three manufacturing facilities in Visakhapatnam, Andhra Pradesh.
6. Company sells its products in 32 countries in Sub-Saharan Africa, South-East Asia and Latin America.
Key Strengths:
1. Leadership in APIs in Select, High Growth Therapeutic Areas
2. Strong R&D Capabilities and Process Chemistry Skills
3. Industry Leading, Modern and Regulatory Compliant Manufacturing Capacities
4. Long-standing Relationships with Multi-National Pharmaceutical Companies
5. Experienced Promoters and Qualified Operational Personnel
6. Established Track Record of Delivering Growth
The Promoters of the company are:
1. Dr Satyanarayana Chava
2. Naga Rani Chava
3. Dr Raju Srihari Kalidindi
4. Ravi Kumar V V and
5. Dr Lakshmana Rao C V
| Particulars | For the year/period ended (in Rs. Million) | ||||
|---|---|---|---|---|---|
| 31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | 31-Mar-12 | |
| Total Assets | 23,083.48 | 18,925.49 | 12,730.58 | 7,009.89 | 5,128.78 |
| Total Revenue | 17,884.15 | 13,603.80 | 11,685.34 | 7,235.67 | 4,523.07 |
| Profit After Tax (PAT) | 1,435.68 | 735.17 | 972.17 | 882.19 | 215.77 |
The object of the issue are to:
1. Pre-payment of term loans; and
2. General corporate purposes.
| Issue Open | Dec 6, 2016 - Dec 8, 2016 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 31,116,785 Eq Shares of ₹10 (aggregating up to ₹1,331.80 Cr) |
| Fresh Issue | 7,009,345 Eq Shares of ₹10 (aggregating up to ₹300.00 Cr) |
| Offer for Sale | 24,107,440 Eq Shares of ₹10 (aggregating up to ₹1,031.80 Cr) |
| Face Value | ₹10 Per Equity Share |
| Issue Price | ₹426 - ₹428 Per Equity Share |
| Market Lot | 35 Shares |
| Min Order Quantity | 35 Shares |
| Listing At | BSE, NSE |
| Bid/Offer Opens On | Dec 6, 2016 |
| Bid/Offer Closes On | Dec 8, 2016 |
| Finalisation of Basis of Allotment | Dec 14, 2016 |
| Initiation of Refunds | Dec 15, 2016 |
| Credit of Shares to Demat Acct | Dec 16, 2016 |
| IPO Shares Listing Date | Dec 19, 2016 |
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 35 | ₹14,980 |
| Maximum | 13 | 455 | ₹194,740 |
No. of Times Issue Subscribed (BSE + NSE) | |||||
|---|---|---|---|---|---|
As on Date & Time | QIB | NII | RII | Employee | Total |
Shares Offered | 6,174,544 | 4,623,879 | 10,789,051 | 323,834 | 21,911,308 |
Dec 8, 2016 18:18 | 10.54x | 3.57x | 1.58x | 1.71x | 4.53x |
| Listing Date | Monday, December 19, 2016 |
| BSE Script Code | 540222 |
| NSE Symbol | LAURUSLABS |
| Listing In | B |
| ISIN | INE947Q01010 |
| Issue Price | ₹428 Per Equity Share |
| Face Value | ₹10 Per Equity Share |
|
|
|
Laurus Labs Ltd
Plot No.21,
Jawaharlal Nehru Pharma City,
Parawada, Visakhapatnam 531 021
Phone: + 91 40 3980 4333
Email: secretarial@lauruslabs.com
Website: http://www.lauruslabs.com
Karvy Computershare Private Limited
Karvy Registry House, 8-2-596, St. No. 1,
Banjara Hills, Hyderabad - 500 034
Andhra Pradesh, India
Phone: +91-40-23312454
Email: einward.ris@karvy.com
Website: https://karisma.karvy.com/
Laurus Labs IPO is an main-board initial public offering of 31,116,785 equity shares of the face value of ₹10 aggregating up to ₹1,331.80 Crores.
The issue price of the IPO is ₹426 - ₹428 Per Equity Share. The minimum order quantity is 35 Shares per application and the offer type is Book Built Issue.
The IPO opens on Dec 6, 2016 and closes on Dec 8, 2016.
Karvy Computershare Private Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Laurus Labs IPO opens on Dec 6, 2016 and closes on Dec 8, 2016.
Laurus Labs IPO application can be done through banks using ASBA online or through stock brokers trading account using UPI. All popular banks i.e. HDFC, ICICI, and SBI offer online IPO applications. An investor can also apply directly through their broker (i.e. Zerodha, Sharekhan) using UPI as a payment method.
The finalization of Basis of Allotment for Laurus Labs IPO will be done on Dec 14, 2016, and the allotted shares will be credited to your demat account by Dec 16, 2016. Check the Laurus Labs IPO allotment status.
Guaranteed Save 60% to 90% Brokerage
You could reduce the brokerage cost significantly by moving to another stock broker. Our expert team compared top share brokers in India to help traders. STOP paying Demat AMC, Brokerage in %, PCM Fee and High Stamp Duty today.
We can help you choosing the right broker. Contact us today...
Useful Articles
|
|
1
|
1
|
2
|
|
|
1
|
|
|
|
|
1
|
1
|
|
|
Best of
Top Stock Brokers in India Top 10 Discount Brokers Top 10 Full-Service Brokers Lifetime Free Demat Account Best Broker for Beginners More Reports...Reviews (Discount Broker)
5paisa (₹10/trade) Zerodha (₹20/trade) ProStocks (₹899 Unlimited) Upstox RKSV (₹20) Edelweiss (₹10 per Trade) More Brokers...Compare Brokers
Broker Articles / Tutorials Compare Share Brokers Side-by-Side Comparison Broker Complaints Monitor Broker Glossary Special OffersTrading Platform Reviews
Zerodha Kite Review Sharekhan TradeTiger Omnesys NEST Review ODIN Review NSE NOW Review More Reviews...Message Board
Stock Message BoardOptions Basics
Options Overview Benefits & Risks of Options Options Pricing More Articles... Options Trading FAQs Options Trading GlossaryBroker Reviews
Zerodha Review 5paisa Review ProStocks Review Sharekhan Review Angel Broking Review ICICI DirectOptions Trading Platform
Kite Zerodha Trade Tiger Sharekhan Omnisys NEST Upstox RKSV Fyers One Fyers ScalperT FinvasiaHistory of Chittorgarh
History of Chittorgarh Maharana Pratap Meera Bai Panna Dhai Rani Padmini Jainism & Chittor (Hindi)Chittorgarh City Info
Chittorgarh City Map Hotels / Resorts Sainik School Chittorgarh Cement Industry Hindustan Zinc
IPO Mentor (600+ Posts, 600+ Likes)
Top Contributor (200+ Posts, 300+ Likes)
IPO Guru (1600+ Posts, 3900+ Likes)